Page 2 - Proprietary Technology News Today

SAN DIEGO, February 13, 2024--Tom Bender, former CooperVision exec, joins MediPrint Ophthalmics as an advisor for innovative drug-delivering contact lenses.

Insightful Analysis of XPO Inc's Financial Health and Strategic Position

On February 5, 2024, Stacy Coen, SVP & CHIEF BUSINESS OFFICER of Immunogen Inc, executed a sale of 4,583 shares of the company.

Exec Edge hosted a fireside chat at the 2024 ICR Conference with Joe Vrankin, CEO of Puttshack. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed its proprietary technology which differentiates the company from competitors and sets it apart as a unique business model, how the company takes advantage of commercial real estate trends and capitalizes […]

Issuer: CureVac / Key word(s): Study results05.01.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platf...

Issuer: CureVac / Key word: Study results CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong...

EcoGraf ASX:EGR ASX Release / 26 March 2024 Product Qualification Facility Commissioning Commenced 'State of the Art' Facility utilising EcoGraf HFfree™ Proprietary Technology to Provide High Purity Battery Anode Material to the Global Battery... - Veroeffentlicht am 26.03.2024

Whenever chaos engulfs a proprietary technology relied on by millions, the default knee-jerk reaction from many seems to be: "." This scenario became all too familiar throughout 2023, as established technologies relied on by millions hit a chaos curve, making people realize how beholden they are to a proprietary platform they have little control over. The OpenAI fiasco in November, where the ChatGPT hit-maker temporarily lost its co-founders, including CEO Sam Altman, created a ...

“One cannot get the consistent compounding like with Asian Paints, but in the case of Tega or say Grindwell Norton in our Rising Giants portfolio, these sorts of companies, you get the upside when the capex cycle is switched on. But you do not get hammered on the downside when the global economy softens up.”

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded. And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, […]